Study to Assess the Distribution, Metabolism and Excretion of [14C]AZD6765 after a Single-Dose Intravenous Administration - AZD6765

Study identifier:D6702C00030

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A Phase I, Open-label, Single-Centre Study to Assess the Distribution, Metabolism and Excretion of [14C]AZD6765 after a Single-Dose Intravenous Administration to Healthy Male Subjects

Medical condition

Major depressive disorder

Phase

Phase 1

Healthy volunteers

Yes

Study drug

-

Sex

Male

Actual Enrollment

6

Study type

Interventional

Age

18 Years - 60 Years

Date

Study Start Date: 01 Sept 2010
Primary Completion Date: 01 Oct 2010
Study Completion Date: 01 Oct 2010

Study design

Allocation: N/A
Endpoint Classification: Safety Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Basic Science

Verification:

Verified 01 Oct 2014 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria